FDA Inspection 1325752 — Baystate Medical Center, Inc.
The FDA completed an inspection of Baystate Medical Center, Inc. on Jun 4, 2026 in Springfield, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 4, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Springfield, MA (United States)